These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 30770960)

  • 1. SCMCIE94: an intensified pilot treatment protocol known to be associated with cure in CD 56-negative non-pelvic isolated Ewing sarcoma (EWS) is also associated with no early relapses in non-metastatic extremity EWS.
    Cohen IJ; Toledano H; Stein J; Kollender Y; Fenig E; Konen O; Bar-Sever Z; Issakov J; Feinmesser M; Avigad S; Ash S
    Cancer Chemother Pharmacol; 2019 May; 83(5):859-866. PubMed ID: 30770960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved Outcome in Local Ewing Sarcoma With an Intensified Pilot Treatment Protocol SCMCIE 94.
    Ash S; Yaniv I; Toledano H; Stein J; Kollender Y; Fenig E; Konen O; Bar-Sever Z; Issakov J; Avigad S; Cohen IJ
    J Pediatr Hematol Oncol; 2019 Mar; 41(2):105-111. PubMed ID: 30570510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonmetastatic pelvic Ewing sarcoma: report of the French society of pediatric oncology.
    Carrie C; Mascard E; Gomez F; Habrand JL; Alapetite C; Oberlin O; Moncho V; Hoffstetter S
    Med Pediatr Oncol; 1999 Nov; 33(5):444-9. PubMed ID: 10531567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Individual risk evaluation for local recurrence and distant metastasis in Ewing sarcoma: A multistate model: A multistate model for Ewing sarcoma.
    Bosma SE; Rueten-Budde AJ; Lancia C; Ranft A; Dirksen U; Krol AD; Gelderblom H; van de Sande MAJ; Dijkstra PDS; Fiocco M
    Pediatr Blood Cancer; 2019 Nov; 66(11):e27943. PubMed ID: 31389188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone marrow involvement identifies a subgroup of advanced Ewing sarcoma patients with fatal outcome irrespective of therapy in contrast to curable patients with multiple bone metastases but unaffected marrow.
    Thiel U; Wawer A; von Luettichau I; Bender HU; Blaeschke F; Grunewald TG; Steinborn M; Röper B; Bonig H; Klingebiel T; Bader P; Koscielniak E; Paulussen M; Dirksen U; Juergens H; Kolb HJ; Burdach SE
    Oncotarget; 2016 Oct; 7(43):70959-70968. PubMed ID: 27486822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New Approaches Promise to Improve Local Ewing Sarcoma Results.
    Cohen IJ; Ash S
    J Pediatr Hematol Oncol; 2022 Aug; 44(6):280-284. PubMed ID: 35537008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrence of Ewing sarcoma: Is detection by imaging follow-up protocol associated with survival advantage?
    Heinemann M; Ranft A; Langer T; Jürgens H; Kreyer J; Vieth V; Schäfers M; Weckesser M; Simon T; Hassenpflug W; Corbacioglu S; Bielack S; Mayer-Steinacker R; Kühne T; van den Berg H; Gelderblom H; Bauer S; Stegger L; Dirksen U
    Pediatr Blood Cancer; 2018 Jul; 65(7):e27011. PubMed ID: 29480574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management and Outcome of Ewing Sarcoma of the Head and Neck.
    Grevener K; Haveman LM; Ranft A; van den Berg H; Jung S; Ladenstein R; Klco-Brosius S; Juergens H; Merks JH; Dirksen U
    Pediatr Blood Cancer; 2016 Apr; 63(4):604-10. PubMed ID: 26702872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term follow up of high-dose chemotherapy with autologous stem cell rescue in adults with Ewing tumor.
    Laurence V; Pierga JY; Barthier S; Babinet A; Alapetite C; Palangié T; de Pinieux G; Anract P; Pouillart P
    Am J Clin Oncol; 2005 Jun; 28(3):301-9. PubMed ID: 15923805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Second malignancy in 597 patients with ewing sarcoma of bone treated at a single institution with adjuvant and neoadjuvant chemotherapy between 1972 and 1999.
    Bacci G; Longhi A; Barbieri E; Ferrari S; Mercuri M; Briccoli A; Versari M; Pignotti E; Picci P
    J Pediatr Hematol Oncol; 2005 Oct; 27(10):517-20. PubMed ID: 16217253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allogeneic and autologous stem-cell transplantation in advanced Ewing tumors. An update after long-term follow-up from two centers of the European Intergroup study EICESS. Stem-Cell Transplant Programs at Düsseldorf University Medical Center, Germany and St. Anna Kinderspital, Vienna, Austria.
    Burdach S; van Kaick B; Laws HJ; Ahrens S; Haase R; Körholz D; Pape H; Dunst J; Kahn T; Willers R; Engel B; Dirksen U; Kramm C; Nürnberger W; Heyll A; Ladenstein R; Gadner H; Jürgens H; Go el U
    Ann Oncol; 2000 Nov; 11(11):1451-62. PubMed ID: 11142486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of the Interdisciplinary Tumor Board of the Cooperative Ewing Sarcoma Study Group on local therapy and overall survival of Ewing sarcoma patients after induction therapy.
    Kreyer J; Ranft A; Timmermann B; Juergens H; Jung S; Wiebe K; Boelling T; Schuck A; Vieth V; Streitbuerger A; Hardes J; Heinemann M; Dirksen U
    Pediatr Blood Cancer; 2018 Dec; 65(12):e27384. PubMed ID: 30084137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pelvis Ewing sarcoma: Local control and survival in the modern era.
    Ahmed SK; Robinson SI; Arndt CAS; Petersen IA; Haddock MG; Rose PS; Issa Laack NN
    Pediatr Blood Cancer; 2017 Sep; 64(9):. PubMed ID: 28244685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival outcomes in pediatric patients with metastatic Ewing sarcoma who achieve a rapid complete response of pulmonary metastases.
    Reiter AJ; Huang L; Craig BT; Davidoff AM; Talbot LJ; Coggins J; Smith J; Aldrink JH; Bergus KC; MacArthur TA; Polites SF; Boehmer C; Brungardt J; Malek MM; Rinehardt HN; Kastenberg ZJ; Arkin CM; Gourmel A; Piche N; Wallace M; Liang J; Lovvorn HN; Petroze RT; Gillies G; Marquart JP; Becktell K; Le HD; Favela J; Rich BS; Glick RD; Seemann NM; Davidson J; Wilson CA; Roach J; Brown EG; Doyle KE; Coakley BA; Emengo P; Merola P; Grant CN; Tirumani A; Tracy ET; Moya-Mendez ME; Dasgupta R; Lautz TB;
    Pediatr Blood Cancer; 2024 Jul; 71(7):e31026. PubMed ID: 38679864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensive combined modality therapy including low-dose TBI in high-risk Ewing's Sarcoma Patients.
    Kinsella TJ; Glaubiger D; Diesseroth A; Makuch R; Waller B; Pizzo P; Glatstein E
    Int J Radiat Oncol Biol Phys; 1983 Dec; 9(12):1955-60. PubMed ID: 9463099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of a multi-modal treatment protocol for Ewing sarcoma--a report from the polish pediatric oncology group.
    Raciborska A; Bilska K; Drabko K; Chaber R; Sobol G; Pogorzała M; Wyrobek E; Połczyńska K; Rogowska E; Rodriguez-Galindo C; Wożniak W
    Pediatr Blood Cancer; 2014 Dec; 61(12):2170-4. PubMed ID: 25163763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What is the impact of local control in Ewing sarcoma: analysis of the first Brazilian collaborative study group - EWING1.
    Becker RG; Gregianin LJ; Galia CR; Jesus-Garcia Filho R; Toller EA; Badell G; Nakagawa SA; David A; Baptista AM; Yonamime ES; Serafini OA; Penna V; Santos JFC; Brunetto AL;
    BMC Cancer; 2017 Jun; 17(1):420. PubMed ID: 28619077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pelvic Ewing sarcoma: a retrospective analysis of 241 cases.
    Hoffmann C; Ahrens S; Dunst J; Hillmann A; Winkelmann W; Craft A; Göbel U; Rübe C; Voute PA; Harms D; Jürgens H
    Cancer; 1999 Feb; 85(4):869-77. PubMed ID: 10091764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of surgery with radiation on pelvic Ewing sarcoma survival.
    Ng VY; Jones R; Bompadre V; Louie P; Punt S; Conrad EU
    J Surg Oncol; 2015 Dec; 112(8):861-5. PubMed ID: 26525492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term Outcomes and Complications in Pediatric Ewing Sarcoma.
    Hamilton SN; Carlson R; Hasan H; Rassekh SR; Goddard K
    Am J Clin Oncol; 2017 Aug; 40(4):423-428. PubMed ID: 25599318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.